Patents Represented by Attorney Choate, Hall & Stewart LLP
  • Patent number: 7854935
    Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of asthma and asthma-related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of asthmatic symptoms in a patient in need thereof.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: December 21, 2010
    Assignee: Herbal Spring, LLC
    Inventors: Xiu-Min Li, Hugh A. Sampson, Ming-Chun Weng
  • Patent number: 7853678
    Abstract: Systems and methods for configuring and evaluating policies that direct processing of one or more data streams are described. A configuration interface is described for allowing users to specify object oriented policies. These object oriented policies may allow any data structures to be applied with respect to a payload of a received packet stream, including any portions of HTTP traffic. A configuration interface may also allow the user to control the order in which policies and policy groups are executed, in addition to specifying actions to be taken if one or more policies are undefined. Systems and methods for processing the policies may allow efficient processing of object-oriented policies by applying potentially complex data structures to unstructured data streams. A device may also interpret and process a number of flow control commands and policy group invocation statements to determine an order of execution among a number of policies and policy groups.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: December 14, 2010
    Assignee: Citrix Systems, Inc.
    Inventors: Prakash Khemani, Vishal Bandekar
  • Patent number: 7853679
    Abstract: Systems and methods for configuring and evaluating policies that direct processing of one or more data streams are described. A configuration interface is described for allowing users to specify object oriented policies. These object oriented policies may allow any data structures to be applied with respect to a payload of a received packet stream, including any portions of HTTP traffic. A configuration interface may also allow the user to control the order in which policies and policy groups are executed, in addition to specifying actions to be taken if one or more policies are undefined. Systems and methods for processing the policies may allow efficient processing of object-oriented policies by applying potentially complex data structures to unstructured data streams. A device may also interpret and process a number of flow control commands and policy group invocation statements to determine an order of execution among a number of policies and policy groups.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: December 14, 2010
    Assignee: Citrix Systems, Inc.
    Inventors: Prakash Khemani, Vishal Bandekar
  • Patent number: 7853947
    Abstract: A method for virtualizing access to named system objects includes the step of receiving a request to access a system object from a process executing in the context of a user isolation scope, the request including a virtual name for the system object. A rule associated with the request is determined and a literal name for the system object is formed in response to the determined rule. A request to access the system object is issued to the operating system. The issued request including the literal name for the system object.
    Type: Grant
    Filed: September 30, 2004
    Date of Patent: December 14, 2010
    Assignee: Citrix Systems, Inc.
    Inventors: Lee George Laborczfalvi, Anil Roychoudhry, Andrew Gerard Borzycki, Jeffrey Dale Muir, Huai Chiun Chin, Richard James Mazzaferri
  • Patent number: 7853558
    Abstract: Embodiments of the present disclosure include methods (and corresponding systems and computer program products) that augment visual elements in documents with rich media content and provide the rich media content based on user interaction with the augmented visual elements in the documents. The disclosed embodiments analyze a document for qualified visual elements. The disclosed embodiments determine keywords associated with the visual element, generate an association of the visual element and the keywords, and embed the association in a corresponding augmented document. When a user reviews the augmented document in a client system and moves a pointer over the augmented visual element, a piece of rich media content related to the keywords are transmitted to the client system to be displayed as an overlay in close proximity to the visual element where the mouse-over occurred.
    Type: Grant
    Filed: February 19, 2008
    Date of Patent: December 14, 2010
    Assignee: Vibrant Media, Inc.
    Inventor: Richard Brindley
  • Patent number: 7851641
    Abstract: As described herein, the present invention provides compounds useful for treating or lessening the severity of a neurodegenerative disorder. The present invention also provides methods of treating or lessening the severity of such disorders wherein said method comprises administering to a patient a compound of the present invention, or composition thereof. Said method is useful for treating or lessening the severity of, for example, Alzheimer's disease.
    Type: Grant
    Filed: May 16, 2006
    Date of Patent: December 14, 2010
    Assignee: Satori Pharmaceuticals, Inc.
    Inventors: Mark A. Findeis, Kollol Pal, Frank Schroeder
  • Patent number: 7851199
    Abstract: The present invention provides systems for producing engineered oleaginous yeast or fungi that express carotenoids.
    Type: Grant
    Filed: March 20, 2006
    Date of Patent: December 14, 2010
    Assignee: Microbia, Inc.
    Inventors: Richard Bailey, Kevin T. Madden, Joshua Trueheart
  • Patent number: 7847235
    Abstract: A novel laser obstacle warning and ranging system, for detecting hard-to-see long and thin obstacles in particular, comprises a fiber laser including a signal diode, a circulator, an erbium doped fiber, a wavelength division multiplexer, a narrow band reflector, a first fiber pump diode, an input combiner, an erbium-ytterbium co-doped fiber, a second fiber pump diode, an output combiner and a third fiber pump diode.
    Type: Grant
    Filed: July 20, 2007
    Date of Patent: December 7, 2010
    Assignee: Elbit Systems Electro-Optics Elop Ltd.
    Inventors: Vladimir Krupkin, Avishay Yaniv, Alla German, Moshe Sarid, Avigdor Zajdman, Elena Luria, Itamar Shoshan
  • Patent number: 7843912
    Abstract: A method for intercepting communication of a client to a destination on a virtual private network includes an agent executing on the client that intercepts a network communication of the client. The agent provides a virtual private network connection from a first network to a second network. The decision to intercept is based on a network destination description or an identification of an application authorized to be accessed via the virtual private network. In one case, the agent determines that a destination specified by the intercepted communication corresponds to a network identifier and a port of a network destination description of an application on the second network authorized for access via the virtual private network. In response to this determination, the agent transmits the intercepted communication.
    Type: Grant
    Filed: August 3, 2006
    Date of Patent: November 30, 2010
    Assignee: Citrix Systems, Inc.
    Inventors: James Harris, Charu Venkatraman, Junxiao He, Amarnath Mullick, Shashi Nanjundaswamy, Ajay Soni
  • Patent number: 7838619
    Abstract: The present invention relates to biodegradable biocompatible polyketals, methods for their preparation, and methods for treating animals by administration of biodegradable biocompatible polyketals. In one aspect, a method for forming the biodegradable biocompatible polyketals comprises combining a glycol-specific oxidizing agent with a polysaccharide to form an aldehyde intermediate, which is combined with a reducing agent to form the biodegradable biocompatible polyketal. The resultant biodegradable biocompatible polyketals can be chemically modified to incorporate additional hydrophilic moieties. A method for treating animals includes the administration of the biodegradable biocompatible polyketal in which biologically active compounds or diagnostic labels can be disposed. The present invention also relates to chiral polyketals, methods for their preparation, and methods for use in chromatographic applications, specifically in chiral separations.
    Type: Grant
    Filed: January 14, 2003
    Date of Patent: November 23, 2010
    Assignee: The General Hospital Corporation
    Inventor: Mikhail I. Papisov
  • Patent number: 7840991
    Abstract: In-theater interactive entertainment system. A game server generates video content in digital form and is displayed on a digital display in a theater. A telephony system is connected to the game server enabling a group of individual game participants in the theater to exchange data wirelessly with the game server so that the game participants can interact with video content on the display. It is preferred that at the display is a reflective screen illuminated by a digital projector.
    Type: Grant
    Filed: August 11, 2003
    Date of Patent: November 23, 2010
    Inventors: Thomas Dusenberry, Joel Kaplan, Mark Rowntree, Donald C. Miffitt, Stephen S. Richardson, Yeasah G. Pell
  • Patent number: 7831833
    Abstract: A secure mechanism for transparent key recovery for a user who has changed authentication information is disclosed. A password manager agent intercepts requests by a user to access secure resources that require user credentials. Upon detecting changed authentication information for the user, the password manager agent automatically regenerates the components of a cryptographic key associated with the user that was previously used to encrypt user credentials for the user and then destroyed. After regeneration of the original cryptographic key, the password manager agent uses the key to decrypt the user credentials necessary for the requested application. The regenerated key is then destroyed and the user credentials are re-encrypted by the password manager agent using a new cryptographic key associated with the user made up of multiple components.
    Type: Grant
    Filed: May 6, 2005
    Date of Patent: November 9, 2010
    Assignee: Citrix Systems, Inc.
    Inventor: Timothy R. Gaylor
  • Patent number: 7829672
    Abstract: A novel tetrodotoxin resistant sodium channel is described, along with isolated nucleotides that encode this receptor. Methods for identifying agents that modulate the Na+ current through the receptor are provided, as well as related therapeutic and diagnostic methods.
    Type: Grant
    Filed: January 4, 2006
    Date of Patent: November 9, 2010
    Assignee: Yale University
    Inventors: Sulayman Dib-Hajj, Stephen G. Waxman
  • Patent number: 7831728
    Abstract: A method for real-time seeking during real-time playback of presentation layer protocol data streams includes the step of receiving, by a foreground protocol engine, a request for rendering the contents of a packet in a presentation layer protocol data stream comprising a first plurality of packets already received and a second plurality of packets yet to be received. The foreground protocol engine identifies a state-snapshot having an associated timestamp previous to that of the requested packet. The foreground protocol engine displays during transmission of the presentation layer protocol data stream from a first device to a second device, the requested packet responsive to the identified state-snapshot.
    Type: Grant
    Filed: November 1, 2006
    Date of Patent: November 9, 2010
    Assignee: Citrix Systems, Inc.
    Inventor: Paul Adam Ryman
  • Patent number: 7825113
    Abstract: The use of a compound comprising formula (I): or a salt, ester, amide or prodrug thereof in the inhibition of an enzyme whose preferred mode of action is to catalyse the hydrolysis of an ester functionality, e.g. in the control and inhibition of unwanted enzymes in products and processes. The compounds are also useful in medicine e.g. in the treatment of obesity and related conditions. The invention also relates to novel compounds within formula (I), to processes for preparing them and pharmaceutical compositions containing them. In formula (I) A is a 6-membered aromatic or heteroaromatic ring; and R1 is a branched or unbranched alkyl (optionally interrupted by one or more oxygen atoms), alkenyl, alkynyl, cycloalkyl, cycloalkenyl, aryl, arylalkyl, reduced arylalkyl, arylalkenyl, heteroaryl, heteroarylalkyl, heteroarylalkenyl, reduced aryl, reduced heteroaryl, reduced heteroarylalkyl or a substituted derivative of any of the foregoing groups.
    Type: Grant
    Filed: November 27, 2002
    Date of Patent: November 2, 2010
    Assignee: Norgine B.V.
    Inventors: Harold Francis Hodson, Robert Downham, Timothy John Mitchell, Beverley Jane Carr, Christopher Robert Dunk, Richard Michael John Palmer
  • Patent number: 7824687
    Abstract: The present invention provides novel clustered multi-antigenic constructs having the structure: and methods for the synthesis thereof. In still another aspect, the present invention provides methods for the treatment of cancer, preferably for the prevention of recurrence of cancer, and methods for inducing antibodies in a subject, comprising administering to a subject in need, an effective amount of any of the inventive constructs as disclosed herein, either in conjugated form or unconjugated and in combination with a suitable immunogenic carrier.
    Type: Grant
    Filed: December 3, 2003
    Date of Patent: November 2, 2010
    Assignee: Sloan-Kettering Institute For Cancer Research
    Inventors: Samuel J. Danishefsky, Stacy J. Keding
  • Patent number: 7827237
    Abstract: Systems and methods of storing previously transmitted data and using it to reduce bandwidth usage and accelerate future communications are described. By using algorithms to identify long compression history matches, a network device may improve compression efficiently and speed. A network device may also use application specific parsing to improve the length and number of compression history matches. Further, by sharing compression histories, compression history indexes and caches across multiple devices, devices can utilize data previously transmitted to other devices to compress network traffic. Any combination of the systems and methods may be used to efficiently find long matches to stored data, synchronize the storage of previously sent data, and share previously sent data among one or more other devices.
    Type: Grant
    Filed: March 12, 2007
    Date of Patent: November 2, 2010
    Assignee: Citrix Systems, Inc.
    Inventor: Robert Plamondon
  • Patent number: 7820175
    Abstract: The present invention provides herbal formulas, and compositions thereof, that can treat or reduce the severity, intensity, or duration of food allergy and food allergy related symptoms. The compositions may optionally include one or more adjuvants, cytokines, encapsulating materials, or pharmaceutically acceptable carriers or excipients, and may be administered prior to, during, or after the development of food allergy-related symptoms in a patient in need thereof.
    Type: Grant
    Filed: March 14, 2005
    Date of Patent: October 26, 2010
    Assignee: Herbal Spring, LLC
    Inventors: Xiu-Min Li, Hugh A. Sampson
  • Patent number: 7820178
    Abstract: An isolated VEGF polypeptide having anti-angiogenic activity, said polypeptide including the amino acid sequence of SEQ. ID NO. 1, or variants thereof.
    Type: Grant
    Filed: July 12, 2002
    Date of Patent: October 26, 2010
    Assignee: University of Brisol
    Inventors: David Bates, Steven Harper
  • Patent number: RE41990
    Abstract: The present invention provides convergent processes for preparing epothilone A and B, desoxyepothilones A and B, and analogues thereof. Also provided are analogues related to epothilone A and B and intermediates useful for preparing same. The present invention further provides novel compositions based on analogues of the epothilones and methods for the treatment of cancer and cancer which has developed a multidrug-resistant phenotype.
    Type: Grant
    Filed: January 4, 2007
    Date of Patent: December 7, 2010
    Assignee: Sloan-Kettering Institute for Cancer Research
    Inventors: Samuel J. Danishefsky, Peter Bertinato, Dai-Shi Su, Dongfang Meng, Ting-Chao Chou, Ted Kamenecka, Erik J. Sorensen, Aaron Balog, Kenneth A. Savin